Systemic inflammation can disrupt neuromuscular function while prolonged immobility reduces normal muscle use. Impaired nerve function adds a neural component, and direct muscle injury contributes a muscular component. These influences can act together rather than independently, helping explain why weakness may be diffuse and why recovery of mobility and independence can be delayed.
Critical illness polyneuropathy primarily signals impaired nerve function, whereas critical illness myopathy emphasizes muscle injury. The two patterns are not mutually exclusive, because either may occur with the other during or after critical illness. Distinguishing their contributions can clarify the neuromuscular problem and guide clinicians toward appropriate assessment, including electrophysiological studies when routine evaluation does not provide enough detail.
Prolonged immobility matters because it is one of several interacting contributors to loss of strength during critical illness. Its effects occur alongside systemic inflammation, impaired nerve function, and muscle injury, so weakness should not be attributed to inactivity alone. Recognizing this multifactorial pattern helps clinicians interpret reduced mobility as a neuromuscular complication requiring assessment and rehabilitation planning.
Clinicians begin with standardized strength testing to document reduced muscle strength in a consistent way. This assessment helps identify the extent of weakness and supports clinical recognition of neuromuscular complications after critical illness. When the findings require further clarification, electrophysiological studies can add information about nerve and muscle involvement, helping distinguish these complications from other causes.
Electrophysiological studies are useful when clinicians need to distinguish neuromuscular complications or clarify whether impaired nerve function, muscle injury, or both contribute to weakness. They complement standardized strength testing rather than replacing clinical assessment. This additional information can refine recognition of critical illness polyneuropathy, critical illness myopathy, or their coexistence, supporting more informed evaluation and follow-up.
Early mobilization and rehabilitation are central supportive strategies for patients affected by this weakness. Careful management of the underlying critical illness also matters because the syndrome develops through interacting systemic and neuromuscular effects. Together, these approaches aim to support functional recovery, improve the return of mobility, and lessen the impact of weakness on independence during recovery.
Recognition has practical consequences beyond diagnosis. Reduced strength can impair recovery, mobility, and independence, so clinicians can use the finding to inform prognosis, discharge planning, and long-term follow-up. Identifying the problem also helps connect acute-care assessment with rehabilitation needs, keeping functional progress and ongoing support part of care after the patient leaves the ICU.